scorecardresearch
Add as a preferred source on Google
Wednesday, January 28, 2026
TopicJ&J

Topic: J&J

J&J’s new flu drug flop shows how difficult it is to fight viruses

Johnson & Johnson stopped developing the drug pimodivir in the final stage of testing it for patients with influenza A, the most common cause of flu, after a study indicated it won't work.

Hip implants dent brand Johnson & Johnson, patients begin questioning other devices

Doctors say Johnson & Johnson's hip implant controversy is causing concern among Indian patients fitted with other devices from the company.

On Camera

Why sharp selloff in Japanese bonds has a message for India’s budget

Although its overall GDP will soon be bigger than Japan’s, on a per-capita basis India is still 12 times poorer.

India’s looking at 14 million metric tonnes of e-waste by 2030, recycling can’t keep up—NITI Aayog

Country's used lithium-ion battery problem is also set to grow sharply in next decade. India 3rd largest e-waste producer with 7% global share but currently recycles only about 10% of it.

Indian Army ties up with US drone company that made its name in the Ukraine conflict

Shield AI will provide V-BAT vertical takeoff & landing drones along with licences for software, which will be integrated into aircraft and made available to select Indian partners.

Non-alignment is coming back in a new avatar: Trump-peedit alliance

No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.